Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1979-10-17
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0026-4725
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
61-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:471237-Administration, Oral,
pubmed-meshheading:471237-Aged,
pubmed-meshheading:471237-Arterial Occlusive Diseases,
pubmed-meshheading:471237-Drug Evaluation,
pubmed-meshheading:471237-Heart,
pubmed-meshheading:471237-Humans,
pubmed-meshheading:471237-Infusions, Parenteral,
pubmed-meshheading:471237-Leg,
pubmed-meshheading:471237-Middle Aged,
pubmed-meshheading:471237-Yohimbine
|
pubmed:articleTitle |
[Use of raubasine in long-term therapy of obliterating arteriopathies].
|
pubmed:publicationType |
Journal Article,
English Abstract
|